Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network.
Illicit drug users sustain the epidemics of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), hepatitis C (HCV), and sexually transmitted infections (STIs). Substance abuse treatment programs present a major intervention point in stemming these epidemics. As a part of the "Infections and Substance Abuse" study, established by the National Drug Abuse Treatment Clinical Trials Network, sponsored by National Institute on Drug Abuse, three surveys were developed; for treatment program administrators, for clinicians, and for state and District of Columbia health and substance abuse department administrators, capturing service availability, government mandates, funding, and other key elements related to the three infection groups. Treatment programs varied in corporate structure, source of revenue, patient census, and medical and non-medical staffing; medical services, counseling services, and staff education targeted HIV/AIDS more often than HCV or STIs. The results from this study have the potential to generate hypotheses for further health services research to inform public policy.
Brown
Lawrence S
LS
Addiction Research and Treatment Corporation, 22 Chapel St, Brooklyn, NY 11201, USA. Lbrown@ARTCNY.org
Kritz
Steven Allan
SA
Goldsmith
R Jeffrey
RJ
Bini
Edmund J
EJ
Rotrosen
John
J
Baker
Sherryl
S
Robinson
Jim
J
McAuliffe
Patrick
P
D000163:Acquired Immunodeficiency Syndrome / Q000209:etiology / Q000517:prevention & control; D002986:Clinical Trials as Topic; D003695:Delivery of Health Care / Q000379:methods / Q000458:organization & administration / Q000706:statistics & numerical data; D015658:HIV Infections / Q000209:etiology / Q000517:prevention & control; D006526:Hepatitis C / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D016730:Program Development; D012749:Sexually Transmitted Diseases / Q000209:etiology / Q000517:prevention & control*; D019966:Substance-Related Disorders / Q000150:complications / Q000628:therapy*; D014481:United States